Susanne Christine Wieland-Berghausen
Novartis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Hotspot
Dive into the research topics where Susanne Christine Wieland-Berghausen is active.
Publication
Featured researches published by Susanne Christine Wieland-Berghausen.
Nature | 2008
Ronald Kaminsky; Pierre Ducray; Martin Jung; Ralph Clover; Lucien Rufener; Jacques Bouvier; Sandra Schorderet Weber; Andre Wenger; Susanne Christine Wieland-Berghausen; Thomas Goebel; Noëlle Gauvry; Francois Pautrat; Thomas Skripsky; Olivier Froelich; Clarisse Komoin-Oka; Bethany Westlund; Ann Sluder; Pascal Mäser
Anthelmintic resistance in human and animal pathogenic helminths has been spreading in prevalence and severity to a point where multidrug resistance against the three major classes of anthelmintics—the benzimidazoles, imidazothiazoles and macrocyclic lactones—has become a global phenomenon in gastrointestinal nematodes of farm animals. Hence, there is an urgent need for an anthelmintic with a new mode of action. Here we report the discovery of the amino-acetonitrile derivatives (AADs) as a new chemical class of synthetic anthelmintics and describe the development of drug candidates that are efficacious against various species of livestock-pathogenic nematodes. These drug candidates seem to have a novel mode of action involving a unique, nematode-specific clade of acetylcholine receptor subunits. The AADs are well tolerated and of low toxicity to mammals, and overcome existing resistances to the currently available anthelmintics.
Journal of Controlled Release | 2002
Susanne Christine Wieland-Berghausen; Uwe Thomas Schote; Michaela Frey; Friederike Schmidt
In this investigation, the water-soluble drugs nitenpyram and clomipramine HCl were encapsulated using coacervation, solvent evaporation and film-coating. The effect of different process factors on the encapsulation efficiency and the release profile of the microparticles was evaluated. For coacervation it was shown that the core to wall ratio was the most important factor. For solvent evaporation using an w/o emulsion the type and concentration of the surfactant were the most important parameters for a successful encapsulation. Additionally the coated material was tested for its stability under different conditions as a powder or compressed into tablets. It could clearly be demonstrated that the coated drug substance exhibited a better stability then the uncoated material. The particles prepared by film-coating showed the best stability.
Parasitology Research | 2008
Ronald Kaminsky; Noëlle Gauvry; S. Schorderet Weber; Thomas Skripsky; Jacques Bouvier; A. Wenger; F. Schroeder; Y. Desaules; R. Hotz; Thomas Goebel; B.C. Hosking; Francois Pautrat; Susanne Christine Wieland-Berghausen; Pierre Ducray
Archive | 2006
Ingolf Macher; Annett Geissler; Susanne Christine Wieland-Berghausen; Uwe Thomas Schote; Ferenc Jozsef Rakoczi
Archive | 2008
Susanne Christine Wieland-Berghausen; Katrin Oppel; Stefan Haas
Archive | 2002
Susanne Christine Wieland-Berghausen; Ferenc Jozsef Rakoczi; Brigitte Monika Cron-Eckhardt
Archive | 2006
Annett Geissler; Ingolf Macher; Ferenc Jozsef Rakoczi; Uwe Thomas Schote; Susanne Christine Wieland-Berghausen
Archive | 2006
Ingolf Macher; Annett Geissler; Susanne Christine Wieland-Berghausen; Uwe Thomas Schote; Ferenc Jozsef Rakoczi
Archive | 2006
Ingolf Macher; Annett Geissler; Susanne Christine Wieland-Berghausen; Uwe Thomas Schote; Ferenc Jozsef Rakoczi
Archive | 2002
Brigitte Monika Cron-Eckhardt; Ferenc Jozsef Rakoczi; Susanne Christine Wieland-Berghausen